DENTSPLY SIRONA ( (XRAY) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
DENTSPLY SIRONA shares are climbing as investors react to the FDA’s clearance of the company’s first MRI system built specifically for dental use, a move seen as a major leap in soft‑tissue imaging technology. The rally is further fueled by strong market confidence linked to a director’s recent insider buying and faith in the firm’s ongoing restructuring program.
That turnaround plan targets about $120 million in annual cost savings, signaling management’s intent to boost profitability and streamline operations. While no specific analyst price targets were mentioned, the combination of breakthrough innovation and cost-cutting momentum is clearly shifting sentiment in favor of the stock.
More about DENTSPLY SIRONA
YTD Price Performance: 2.62%
Average Trading Volume: 4,681,999
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.34B
For further insights into XRAY stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.